| Schedule of Restatement |
Schedule
of Restatement
| | |
Successor | | |
Successor | |
| | |
Three Months | | |
Period from June 7 | |
| | |
Ended | | |
through | |
| | |
October 31, 2025 | | |
October 31, 2025 | |
| (Overstatement)/Understatement | |
| | | |
| | |
| Basic Net Income per share | |
$ | (0.21 | ) | |
$ | (0.45 | ) |
| Diluted Net Income per share | |
$ | (0.21 | ) | |
$ | (0.45 | ) |
| Basic weighted average number of common shares outstanding | |
| 2,214,508 | | |
| 1,857,056 | |
| Diluted weighted average number of common shares outstanding | |
| 2,214,508 | | |
| 857,057 | |
Condensed
Consolidated Statement of Operations (Unaudited)
| | |
Successor | | |
Successor | | |
Successor | | |
Successor | | |
Successor | | |
Successor | |
| | |
Successor | |
| | |
Three Months Ended October 31, 2025 | | |
Period
from June 7 through October 31, 2025 | |
| | |
As Previously Reported | | |
Restatement Adjustments | | |
As Restated | | |
As Previously Reported | | |
Restatement Adjustments | | |
As Restated | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Net income (loss) | |
$ | 283,642,773 | | |
$ | - | | |
$ | 283,642,773 | | |
$ | 277,794,376 | | |
$ | - | | |
$ | 277,794,376 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Net income per share of common stock attributable to common stockholders | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Basic | |
$ | 5.39 | | |
$ | (0.21 | ) | |
$ | 5.18 | | |
$ | 8.47 | | |
$ | (0.45 | ) | |
$ | 8.02 | |
| Diluted | |
$ | 5.36 | | |
$ | (0.21 | ) | |
$ | 5.15 | | |
$ | 8.43 | | |
$ | (0.45 | ) | |
$ | 7.98 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of common shares outstanding | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Basic | |
| 52,586,930 | | |
| 2,214,508 | | |
| 54,801,438 | | |
| 32,780,642 | | |
| 1,857,056 | | |
| 34,637,698 | |
| Diluted | |
| 52,901,925 | | |
| 2,214,508 | | |
| 55,116,433 | | |
| 33,960,249 | | |
| 857,057 | | |
| 34,817,306 | |
|